Trigeminal Neuralgia Clinical Trial
Official title:
RAD 1501: A Phase II Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery
Verified date | March 2024 |
Source | University of Alabama at Birmingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To determine the feasibility of frameless Virtual Cone trigeminal neuralgia radiosurgery at a single institution prior to multi-institutional enrollment.
Status | Active, not recruiting |
Enrollment | 40 |
Est. completion date | October 2025 |
Est. primary completion date | October 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility | Inclusion Criteria: - Patients with trigeminal neuralgia pain that is not well controlled despite medical management (BNI 4 OR BNI 5) - Patients must have an ECOG status of 0, 1, or 2 - Patients must be at least 18 years of age - Life expectancy must be greater than 12 months - MRI of brain within prior 12 months to confirm lack of other causes of facial pain - All patients must be given written informed consent Exclusion Criteria: - Patients who have had prior brain radiosurgery or therapeutic radiation therapy to the pons - Patients with atypical trigeminal neuralgia or headache pain syndromes - Patients with pain associated with multiple sclerosis or base of skull tumor - Patients with medical contra-indications to MR imaging (e.g. pacemaker) |
Country | Name | City | State |
---|---|---|---|
United States | Hazelrig-Salter Radiation Oncology Center | Birmingham | Alabama |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of Frameless Virtual Cone Trigeminal Neuralgia Radiosurgery as assessed by number of participants that completed treatment | 3 Month Follow-Up Visit | ||
Primary | The mean of Barrow Neurologic Institute Pain Intensity Score (BNI) (pain relief score) between the two arms. | Pain Relief Score designed to assess trigeminal neuralgia associated pain. It ranges from "I" being "no trigeminal pain, no medication" to "V" being "severe pain/no pain relief". | 1 Year | |
Secondary | Number of Participants with treatment-related adverse events | Based on the assessments of the patient and the responses provided by the patient in questionnaires, we will assess acute and late neurologic toxicities. All adverse events/toxicities will be assessed with the utilization of CTCAE v.4.0. | 1 Year | |
Secondary | Mean of Quality of Life Scores as measured by SF-36 Questionnaire | Quality of Life (QOL) will be measured by SF-36. This questionnaire consists of 36 questions (items) measuring physical and mental health in relation to 8 health concepts: physical functioning, bodily pain, role of limitations due to physical health problems, role of limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perception. All items are scored so that a high score defines a more favorable health state. Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are set at 0 and 100, respectively. | 1 Year | |
Secondary | Patient Satisfaction Scores | 3 months following the completion of radiosurgery, the patient will be asked the following two questions: 1) Would you have the radiosurgery procedure again? 2) Would you recommend it to friends and family? | 3 Month Follow-Up Visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05152368 -
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy
|
Phase 1 | |
Recruiting |
NCT02801630 -
An Evaluation of the Effect of a Surface Acoustic Wave Patch Device on the Symptons of Trigeminal Neuralgia
|
N/A | |
Completed |
NCT02473016 -
Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
|
Phase 2 | |
Recruiting |
NCT01364259 -
A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia
|
Phase 3 | |
Completed |
NCT01364272 -
Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
|
||
Completed |
NCT00913107 -
Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia
|
Phase 2/Phase 3 | |
Completed |
NCT00603694 -
Hippocampal Radiation Exposure and Memory
|
N/A | |
Recruiting |
NCT04996199 -
Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical Trial
|
Phase 4 | |
Completed |
NCT06240494 -
Predictive Factors in Maxillary and Mandibular Nerve Radiofrequency Treatment for Trigeminal Neuralgia
|
||
Completed |
NCT05712993 -
Comparative Study Between Transcoronoid and Infrazygomatic Anterior Maneuvers
|
N/A | |
Completed |
NCT04371575 -
Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients
|
||
Completed |
NCT03669744 -
Regional Anesthesia in Refractory Trigeminal Neuralgia: 21 Cases Reported to the Limoges University Hospital
|
||
Completed |
NCT05032573 -
Feasibility of Olive Oil for Reducing Facial Pain of Trigeminal Neuralgia
|
N/A | |
Recruiting |
NCT05615714 -
Paresthesia-free Peripheral Nerve Field Stimulation for Trigeminal Neuralgia (FreeST Trial)
|
Phase 1/Phase 2 | |
Recruiting |
NCT04054024 -
Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia
|
Phase 2 | |
Not yet recruiting |
NCT05451251 -
Deep Brain Stimulation for Refractory Trigeminal Neuralgia With a Demyelinating Pontine Lesion
|
N/A | |
Withdrawn |
NCT04353505 -
Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
|
Phase 1 | |
Withdrawn |
NCT01932255 -
CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
|
N/A | |
Completed |
NCT05075707 -
Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia
|
N/A | |
Completed |
NCT06334796 -
Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
|
Early Phase 1 |